Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79,643,662
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
9,423,304
-
Shares change
-
+1,105,717
-
Total reported value, excl. options
-
$74,527,000
-
Value change
-
+$5,445,356
-
Number of buys
-
17
-
Number of sells
-
-11
-
Price
-
$7.91
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q2 2021
35 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,423,304 shares
of 79,643,662 outstanding shares and own 11.83% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (1,415,500 shares), FMR LLC (1,349,211 shares), Logos Global Management LP (1,339,793 shares), BVF INC/IL (1,113,435 shares), Woodline Partners LP (857,445 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (853,208 shares), MORGAN STANLEY (851,004 shares), Ikarian Capital, LLC (350,000 shares), JANUS HENDERSON GROUP PLC (245,095 shares), and VANGUARD GROUP INC (209,750 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.